NORTHERN TRUST CORP - HARVARD BIOSCIENCE INC ownership

HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 67 filers reported holding HARVARD BIOSCIENCE INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of HARVARD BIOSCIENCE INC
ValueSharesWeighting
Q3 2023$2,006,845
-20.8%
466,708
+1.1%
0.00%
Q2 2023$2,533,097
+213.6%
461,402
+139.9%
0.00%
Q1 2023$807,655
+52.7%
192,299
+0.7%
0.00%
Q4 2022$528,837
+7.9%
190,916
-0.3%
0.00%
Q3 2022$490,000
-77.8%
191,545
-68.8%
0.00%
Q2 2022$2,211,000
-22.0%
614,115
+34.5%
0.00%
Q1 2022$2,834,000
-16.3%
456,484
-4.9%
0.00%
-100.0%
Q4 2021$3,385,000
-1.0%
480,242
-2.0%
0.00%0.0%
Q3 2021$3,419,000
-17.6%
489,892
-1.7%
0.00%0.0%
Q2 2021$4,150,000
+57.3%
498,148
+3.0%
0.00%
Q1 2021$2,639,000
-0.3%
483,477
-21.6%
0.00%
-100.0%
Q4 2020$2,646,000
+36.7%
616,983
-4.0%
0.00%
Q3 2020$1,935,000
+63.2%
642,750
+67.9%
0.00%
Q2 2020$1,186,000
+238.9%
382,789
+141.1%
0.00%
Q1 2020$350,000
-27.1%
158,792
+0.8%
0.00%
Q4 2019$480,000
-1.4%
157,545
-0.6%
0.00%
Q3 2019$487,000
-43.2%
158,445
-63.0%
0.00%
Q2 2019$857,000
-55.4%
428,344
-3.9%
0.00%
Q1 2019$1,921,000
+36.3%
445,730
+0.6%
0.00%
Q4 2018$1,409,000
-39.3%
443,224
+0.2%
0.00%
-100.0%
Q3 2018$2,321,000
+10.9%
442,190
+13.0%
0.00%0.0%
Q2 2018$2,093,000
+370.3%
391,154
+339.6%
0.00%
Q1 2018$445,000
+48.8%
88,970
-1.8%
0.00%
Q4 2017$299,000
-6.6%
90,621
+6.1%
0.00%
Q3 2017$320,000
+45.5%
85,405
-0.9%
0.00%
Q2 2017$220,000
+3.3%
86,205
+5.2%
0.00%
Q1 2017$213,000
-11.2%
81,945
+4.1%
0.00%
Q4 2016$240,000
+16.5%
78,736
+3.8%
0.00%
Q3 2016$206,000
-4.2%
75,852
+0.7%
0.00%
Q2 2016$215,000
-78.8%
75,357
-77.6%
0.00%
Q1 2016$1,015,000
-12.4%
336,249
+0.7%
0.00%
Q4 2015$1,159,000
-8.5%
334,024
-0.3%
0.00%
Q3 2015$1,267,000
+135.9%
335,118
+255.9%
0.00%
Q2 2015$537,000
+34.9%
94,173
+37.8%
0.00%
Q1 2015$398,000
-8.7%
68,327
-11.1%
0.00%
Q4 2014$436,000
+38.4%
76,900
-0.1%
0.00%
Q3 2014$315,000
-75.8%
77,004
-73.1%
0.00%
Q2 2014$1,302,000
-17.9%
286,336
-14.4%
0.00%
Q1 2014$1,586,000
-5.6%
334,484
-6.4%
0.00%
-100.0%
Q4 2013$1,680,000
-11.0%
357,320
-0.4%
0.00%0.0%
Q3 2013$1,887,000
+12.1%
358,774
+0.2%
0.00%0.0%
Q2 2013$1,684,000358,1130.00%
Other shareholders
HARVARD BIOSCIENCE INC shareholders Q1 2023
NameSharesValueWeighting ↓
AMH Equity Ltd 2,053,907$8,626,4099.88%
B. Riley Asset Management, LLC 3,408,796$14,316,9435.93%
Meros Investment Management, LP 1,124,206$4,721,6652.69%
Harvey Partners, LLC 2,712,700$11,393,3401.41%
Archon Capital Management LLC 1,361,769$5,719,4301.28%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 2,947,329$12,378,7820.80%
BARD ASSOCIATES INC 291,297$1,223,4480.50%
Portolan Capital Management 1,043,546$4,382,8930.42%
HEARTLAND ADVISORS INC 1,200,000$5,040,0000.31%
EAM Investors, LLC 345,546$1,451,2930.28%
View complete list of HARVARD BIOSCIENCE INC shareholders